• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子直接蛋白质靶标的鉴定。

Identification of direct protein targets of small molecules.

机构信息

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, 90095, United States.

出版信息

ACS Chem Biol. 2011 Jan 21;6(1):34-46. doi: 10.1021/cb100294v. Epub 2010 Nov 30.

DOI:10.1021/cb100294v
PMID:21077692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3031183/
Abstract

Small-molecule target identification is a vital and daunting task for the chemical biology community as well as for researchers interested in applying the power of chemical genetics to impact biology and medicine. To overcome this "target ID" bottleneck, new technologies are being developed that analyze protein-drug interactions, such as drug affinity responsive target stability (DARTS), which aims to discover the direct binding targets (and off targets) of small molecules on a proteome scale without requiring chemical modification of the compound. Here, we review the DARTS method, discuss why it works, and provide new perspectives for future development in this area.

摘要

小分子靶标鉴定是化学生物学领域以及将化学遗传学应用于生物学和医学领域的研究人员面临的一项艰巨而重要的任务。为了克服这一“靶标 ID”瓶颈,正在开发新的技术来分析蛋白质-药物相互作用,如药物亲和反应靶标稳定性(DARTS),旨在在不要求化合物化学修饰的情况下,在蛋白质组范围内发现小分子的直接结合靶标(和脱靶)。在这里,我们回顾了 DARTS 方法,讨论了它为什么有效,并为该领域的未来发展提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/db22a7a210fc/cb-2010-00294v_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/b90bfee26f3a/cb-2010-00294v_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/d2b58bfa9d3f/cb-2010-00294v_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/db22a7a210fc/cb-2010-00294v_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/b90bfee26f3a/cb-2010-00294v_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/d2b58bfa9d3f/cb-2010-00294v_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab7/3031183/db22a7a210fc/cb-2010-00294v_0003.jpg

相似文献

1
Identification of direct protein targets of small molecules.小分子直接蛋白质靶标的鉴定。
ACS Chem Biol. 2011 Jan 21;6(1):34-46. doi: 10.1021/cb100294v. Epub 2010 Nov 30.
2
Chemical proteomics: terra incognita for novel drug target profiling.化学蛋白质组学:新型药物靶点分析的未知领域。
Chin J Cancer. 2012 Nov;31(11):507-18. doi: 10.5732/cjc.011.10377. Epub 2012 May 23.
3
Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application.药物亲和力反应靶标稳定性(DARTS)加速小分子靶标发现:原理与应用。
Biochem Pharmacol. 2021 Dec;194:114798. doi: 10.1016/j.bcp.2021.114798. Epub 2021 Oct 19.
4
Target profiling of small molecules by chemical proteomics.通过化学蛋白质组学对小分子进行靶点分析
Nat Chem Biol. 2009 Sep;5(9):616-24. doi: 10.1038/nchembio.216.
5
Profiling the Protein Targets of Unmodified Bio-Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry.应用药物亲和反应靶标稳定性和液相色谱/串联质谱技术对未经修饰的生物活性分子的蛋白质靶标进行分析。
Proteomics. 2020 May;20(9):e1900325. doi: 10.1002/pmic.201900325. Epub 2020 Feb 5.
6
[The application of small molecule bioactive probes in the identification of cellular targets].小分子生物活性探针在细胞靶点鉴定中的应用
Yao Xue Xue Bao. 2012 Mar;47(3):299-306.
7
Drug affinity responsive target stability (DARTS) for small-molecule target identification.用于小分子靶点鉴定的药物亲和力响应靶点稳定性(DARTS)
Methods Mol Biol. 2015;1263:287-98. doi: 10.1007/978-1-4939-2269-7_22.
8
Identification of protein binding partners of small molecules using label-free methods.使用无标记方法鉴定小分子的蛋白质结合伴侣。
Expert Opin Drug Discov. 2016 Oct;11(10):1017-25. doi: 10.1080/17460441.2016.1227316. Epub 2016 Aug 31.
9
Chemoproteomic-enabled phenotypic screening.基于化学蛋白质组学的表型筛选。
Cell Chem Biol. 2021 Mar 18;28(3):371-393. doi: 10.1016/j.chembiol.2021.01.012. Epub 2021 Feb 11.
10
[Chemical proteomics and discovery of drug targets].[化学蛋白质组学与药物靶点的发现]
Yao Xue Xue Bao. 2011 Aug;46(8):877-82.

引用本文的文献

1
Identification of small GTPases as potential target proteins of the mycotoxin and renal carcinogen ochratoxin A.鉴定小GTP酶作为霉菌毒素和肾脏致癌物赭曲霉毒素A的潜在靶蛋白。
Arch Toxicol. 2025 Sep 11. doi: 10.1007/s00204-025-04189-8.
2
Multi-Trait Polygenic Scores for COPD and COPD Exacerbations Implicate Druggable Proteins.慢性阻塞性肺疾病(COPD)和COPD急性加重的多性状多基因评分涉及可成药蛋白。
medRxiv. 2025 Aug 26:2025.08.22.25334001. doi: 10.1101/2025.08.22.25334001.
3
Sinapic Acid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents That Target Transforming Growth Factor β‑Activated Kinase 1 (TAK1).

本文引用的文献

1
Atomic-level characterization of the structural dynamics of proteins.原子水平上蛋白质结构动力学的特性描述。
Science. 2010 Oct 15;330(6002):341-6. doi: 10.1126/science.1187409.
2
Biochemical target isolation for novices: affinity-based strategies.新手的生化靶点分离:基于亲和力的策略。
Chem Biol. 2010 Jun 25;17(6):616-23. doi: 10.1016/j.chembiol.2010.05.015.
3
Discovery of a proneurogenic, neuroprotective chemical.发现一种具有促神经发生和神经保护作用的化学物质。
芥子酸共轭钆配合物作为靶向转化生长因子β激活激酶1(TAK1)的抗炎诊疗试剂
ACS Pharmacol Transl Sci. 2025 Jun 2;8(6):1814-1831. doi: 10.1021/acsptsci.5c00220. eCollection 2025 Jun 13.
4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.基于mRNA和核糖核蛋白的疗法的进展与挑战:从递送系统到临床应用
Mol Ther Nucleic Acids. 2024 Aug 19;35(3):102313. doi: 10.1016/j.omtn.2024.102313. eCollection 2024 Sep 10.
5
The Effects and Mechanism of ATM Kinase Inhibitors in .ATM 激酶抑制剂在. 中的作用及机制
Int J Mol Sci. 2024 Jun 25;25(13):6947. doi: 10.3390/ijms25136947.
6
Advances in Integrated Multi-omics Analysis for Drug-Target Identification.整合多组学分析在药物靶点识别中的进展。
Biomolecules. 2024 Jun 14;14(6):692. doi: 10.3390/biom14060692.
7
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products.天然产物结构-活性关系研究方法的进展、机遇与挑战。
Nat Prod Rep. 2024 Oct 17;41(10):1543-1578. doi: 10.1039/d4np00009a.
8
Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches.基于 MS 蛋白质组学方法发现的三萜烯酸作为脂肪酸合酶相互作用的抗癌靶点。
Int J Mol Sci. 2024 May 29;25(11):5918. doi: 10.3390/ijms25115918.
9
Stability-based approaches in chemoproteomics.基于稳定性的化学蛋白质组学方法。
Expert Rev Mol Med. 2024 Apr 12;26:e6. doi: 10.1017/erm.2024.6.
10
Novel Fluorescent Strategy for Discriminating T and B Lymphocytes Using Transport System.利用转运系统区分T淋巴细胞和B淋巴细胞的新型荧光策略
Pharmaceutics. 2024 Mar 19;16(3):424. doi: 10.3390/pharmaceutics16030424.
Cell. 2010 Jul 9;142(1):39-51. doi: 10.1016/j.cell.2010.06.018.
4
Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase.化学遗传学筛选雷帕霉素增强子鉴定出一种特异性的 SCF 家族 E3 泛素连接酶抑制剂。
Nat Biotechnol. 2010 Jul;28(7):738-42. doi: 10.1038/nbt.1645. Epub 2010 Jun 27.
5
Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements.基于蛋白质稳定性测量的定量蛋白质组学方法鉴定复杂混合物中的蛋白-药物相互作用。
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9078-82. doi: 10.1073/pnas.1000148107. Epub 2010 May 3.
6
Natural products and their biological targets: proteomic and metabolomic labeling strategies.天然产物及其生物靶点:蛋白质组学和代谢组学标记策略。
Angew Chem Int Ed Engl. 2010 Apr 1;49(15):2680-98. doi: 10.1002/anie.200905352.
7
MS-driven protease substrate degradomics.基于 MS 的蛋白酶底物降解组学。
Proteomics. 2010 Mar;10(6):1284-96. doi: 10.1002/pmic.200900418.
8
Synthesis of S-adenosyl-L-homocysteine capture compounds for selective photoinduced isolation of methyltransferases.S-腺苷同型半胱氨酸捕获化合物的合成及其用于选择性光诱导甲基转移酶的分离。
Chembiochem. 2010 Jan 25;11(2):256-65. doi: 10.1002/cbic.200900349.
9
Target identification using drug affinity responsive target stability (DARTS).利用药物亲和反应靶标稳定性(DARTS)进行靶标鉴定。
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21984-9. doi: 10.1073/pnas.0910040106. Epub 2009 Dec 7.
10
Methods for the proteomic identification of protease substrates.蛋白酶底物的蛋白质组学鉴定方法。
Curr Opin Chem Biol. 2009 Dec;13(5-6):503-9. doi: 10.1016/j.cbpa.2009.07.026. Epub 2009 Sep 2.